Levora
Product Images NDC 42254-260

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Levora (NDC 42254-260). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Rebel Distributors Corp, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image 1 (684602ed 06c6 4633 B587 135c616f091e 01)

Chemical structure of the active ingredient in Levora, showing a steroidal backbone with multiple rings, hydroxyl, ketone, ethyl, and ethynyl functional groups.*

FDA Label Image

Image 2 (684602ed 06c6 4633 B587 135c616f091e 02)

Chemical structure diagram of the active ingredient in Levora, depicting the molecular arrangement including a phenol group, several rings, hydroxyl groups, and an alkyne side chain.*

FDA Label Image

Image 3 (684602ed 06c6 4633 B587 135c616f091e 03)

A bar chart depicting mortality rates (number of deaths per 100,000 woman years) by age group (15-24, 25-34, 35-44, 45+) for four groups: ever-users non-smokers, controls non-smokers, ever-users smokers, and controls smokers. The data shows mortality rates increasing with age, particularly higher in ever-users smokers compared to other groups.*

FDA Label Image

Image 4 (684602ed 06c6 4633 B587 135c616f091e 04)

Levora 0.15/30-28 oral contraceptive tablet blister pack labeling showing a 28-day cycle with days of the week (Sunday to Saturday) arranged in four rows representing weeks 1 to 4. The active ingredients levonorgestrel 0.15 mg and ethinyl estradiol 0.03 mg are indicated. Arrows guide the user through the daily pill sequence, with a note that tablets in week 4 are inactive and a monthly breast exam reminder.*

FDA Label Image

Levora 0.15mg/0.03mg (684602ed 06c6 4633 B587 135c616f091e 05)

Packaging label for Levora 0.15 mg / 0.03 mg tablets, a 28-day regimen with 1 pack of 28 tablets. The label shows the product is distributed by Physician Partner and manufactured by Patheon Inc. in Mississauga, Ontario, Canada. It includes instructions to store at controlled room temperature and keep medication out of children's reach.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.